Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder.
暂无分享,去创建一个
Tommaso Scarabino | Giuseppe Blasi | Alessandro Bertolino | Joseph H Callicott | Daniel R Weinberger | Antonello Bellomo | Mario Altamura | T. Goldberg | J. Callicott | D. Weinberger | G. Blasi | A. Bertolino | A. Bellomo | M. Altamura | T. Scarabino | M. Nardini | Terry E Goldberg | Marcello Nardini | Domenico Sciota | Flora Brudaglio | Nicola Antonucci | Nicola Antonucci | F. Brudaglio | Domenico Sciota
[1] S. Bluml,et al. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by 13C MRS and [1-13C]glucose infusion , 2001 .
[2] J. Vion-Dury,et al. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy , 1995, The Lancet.
[3] R. Coppola,et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. , 1999, Cerebral cortex.
[4] R. Lenkinski,et al. The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons , 1995, Neuroscience Letters.
[5] Steven Warach,et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI , 1999, Biological Psychiatry.
[6] J A Frank,et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. , 2000, The American journal of psychiatry.
[7] K. Bhakoo,et al. In Vitro Expression of N‐Acetyl Aspartate by Oligodendrocytes , 2000, Journal of neurochemistry.
[8] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[9] W. Brooks,et al. Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[10] Edward E. Smith,et al. Temporal dynamics of brain activation during a working memory task , 1997, Nature.
[11] Raquel E Gur,et al. Proton Magnetic Resonance Spectroscopy in the Frontal and Temporal Lobes of Neuroleptic Naive Patients with Schizophrenia , 1999, Neuropsychopharmacology.
[12] P. Matthews,et al. Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.
[13] B L Hart,et al. Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain. , 1999, Neuroreport.
[14] K O Lim,et al. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. , 1998, Archives of general psychiatry.
[15] Robert Bartha,et al. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients , 1999, Biological Psychiatry.
[16] J. Clark,et al. N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction , 1998, Developmental Neuroscience.
[17] N. Schuff,et al. Method to correlate 1H MRSI and 18FDG‐PET , 2000, Magnetic resonance in medicine.
[18] Corey C. Ford,et al. Frontal lobe of children with schizophrenia spectrum disorders: A proton magnetic resonance spectroscopic study , 1998, Biological Psychiatry.
[19] G Tedeschi,et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. , 1996, The American journal of psychiatry.
[20] K O Lim,et al. In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.
[21] R. Kuzniecky,et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging , 1996, Annals of neurology.
[22] R. Coppola,et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.
[23] T. Serikawa,et al. The Effects of Lithium Chloride and Other Substances on Levels of Brain N-Acetyl-L-Aspartic Acid in Canavan Disease-Like Rats , 2002, Neurochemical Research.
[24] D. Braus,et al. Favorable Effect on Neuronal Viability in the Anterior Cingulate Gyrus due to Long-Term Treatment with Atypical Antipsychotics: An MRSI Study , 2001, Pharmacopsychiatry.
[25] Peter M. G. Munro,et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.
[26] M. Egan,et al. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. , 2000, The American journal of psychiatry.
[27] O. Andreassen,et al. Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice , 2000, Journal of neurochemistry.
[28] M. Weiner,et al. Decreased left frontal lobe N-acetylaspartate in schizophrenia. , 1997, The American journal of psychiatry.
[29] P. Dannon,et al. A Follow-up Study of Patients with DSM-IV Schizophreniform Disorder , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[30] B. Hart,et al. Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury. , 1998, AJNR. American journal of neuroradiology.
[31] John Lauriello,et al. Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia , 2001, Psychiatry Research: Neuroimaging.
[32] Marc Laruelle,et al. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies , 2000, Psychiatry Research: Neuroimaging.
[33] Alessandro Bertolino,et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia , 2001, Biological Psychiatry.
[34] Dieter F. Braus,et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia , 2000, Schizophrenia Research.
[35] P. Goldman-Rakic,et al. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia , 1999, Biological Psychiatry.